scispace - formally typeset
E

Eva Rohde

Researcher at Paracelsus Private Medical University of Salzburg

Publications -  79
Citations -  14823

Eva Rohde is an academic researcher from Paracelsus Private Medical University of Salzburg. The author has contributed to research in topics: Mesenchymal stem cell & Progenitor cell. The author has an hindex of 28, co-authored 67 publications receiving 9786 citations. Previous affiliations of Eva Rohde include University of Graz & Medical University of Graz.

Papers
More filters
Journal ArticleDOI

Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

Clotilde Théry, +417 more
TL;DR: The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities, and a checklist is provided with summaries of key points.
Journal ArticleDOI

Biological properties of extracellular vesicles and their physiological functions

María Yáñez-Mó, +72 more
TL;DR: A comprehensive overview of the current understanding of the physiological roles of EVs is provided, drawing on the unique EV expertise of academia-based scientists, clinicians and industry based in 27 European countries, the United States and Australia.
Journal ArticleDOI

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper

Thomas Lener, +57 more
TL;DR: In this paper, the authors summarize recent developments and the current knowledge of extracellular vesicles (EVs) and discuss safety and regulatory requirements that must be considered for pharmaceutical manufacturing and clinical application.
Journal ArticleDOI

Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.

TL;DR: This work has shown that MSC propagation from fetal bovine serum is a major barrier to translation of auspicious experimental results into clinical applications for regenerative and immunomodulatory cellular therapies.
Journal ArticleDOI

Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine

TL;DR: The high potential of nanosized EVs for both diagnostic and therapeutic areas of nanomedicine, as demonstrated by the European Network on Microvesicles and Exosomes in Health and Disease (ME-HAD), is demonstrated.